IN185228B - - Google Patents

Info

Publication number
IN185228B
IN185228B IN90BO1999A IN185228B IN 185228 B IN185228 B IN 185228B IN 90BO1999 A IN90BO1999 A IN 90BO1999A IN 185228 B IN185228 B IN 185228B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Bakulesh Mafatlal Dr Khamar
Original Assignee
Bakulesh Mafatlal Dr Khamar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bakulesh Mafatlal Dr Khamar filed Critical Bakulesh Mafatlal Dr Khamar
Priority to IN90BO1999 priority Critical patent/IN185228B/en
Priority to APAP/P/2000/001977A priority patent/AP2000001977A0/en
Priority to EP00925571A priority patent/EP1139970A2/en
Priority to AU44291/00A priority patent/AU4429100A/en
Priority to CA002326690A priority patent/CA2326690A1/en
Priority to PCT/IN2000/000008 priority patent/WO2000049990A2/en
Priority to IL13882400A priority patent/IL138824A0/xx
Priority to IDW20002252A priority patent/ID28121A/id
Priority to BR0004530-6A priority patent/BR0004530A/pt
Priority to EA200000918A priority patent/EA200000918A1/ru
Priority to ZA200006252A priority patent/ZA200006252B/en
Publication of IN185228B publication Critical patent/IN185228B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
IN90BO1999 1999-02-03 1999-02-03 IN185228B (el)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IN90BO1999 IN185228B (el) 1999-02-03 1999-02-03
APAP/P/2000/001977A AP2000001977A0 (en) 1999-02-03 2000-02-02 The process for manufacturing topical opthalmic preparations without systemic effects.
EP00925571A EP1139970A2 (en) 1999-02-03 2000-02-02 The process for manufacturing topical ophthalmic preparations without systemic effects
AU44291/00A AU4429100A (en) 1999-02-03 2000-02-02 The process for manufacturing topical ophthalmic preparations without systemic effects
CA002326690A CA2326690A1 (en) 1999-02-03 2000-02-02 The process for manufacturing topical ophthalmic preparations without systemic effects
PCT/IN2000/000008 WO2000049990A2 (en) 1999-02-03 2000-02-02 The process for manufacturing topical ophthalmic preparations without systemic effects
IL13882400A IL138824A0 (en) 1999-02-03 2000-02-02 Process for manufacturing topical ophthalmic preparations without systemic effects
IDW20002252A ID28121A (id) 1999-02-03 2000-02-02 Proses pembuatan sediaan-sediaan optalmik topikal tanpa efek-efek sistematik
BR0004530-6A BR0004530A (pt) 1999-02-03 2000-02-02 Processo para manufaturamento de preparações oftálmicas tópicas sem efeitos sistêmicos
EA200000918A EA200000918A1 (ru) 1999-02-03 2000-02-02 Способ изготовления глазных препаратов местного применения без общих действий
ZA200006252A ZA200006252B (en) 1999-02-03 2000-11-01 The process for manufacturing topical ophthalmic preparations without systemic effects.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN90BO1999 IN185228B (el) 1999-02-03 1999-02-03

Publications (1)

Publication Number Publication Date
IN185228B true IN185228B (el) 2000-12-09

Family

ID=11077485

Family Applications (1)

Application Number Title Priority Date Filing Date
IN90BO1999 IN185228B (el) 1999-02-03 1999-02-03

Country Status (11)

Country Link
EP (1) EP1139970A2 (el)
AP (1) AP2000001977A0 (el)
AU (1) AU4429100A (el)
BR (1) BR0004530A (el)
CA (1) CA2326690A1 (el)
EA (1) EA200000918A1 (el)
ID (1) ID28121A (el)
IL (1) IL138824A0 (el)
IN (1) IN185228B (el)
WO (1) WO2000049990A2 (el)
ZA (1) ZA200006252B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
AU7326901A (en) * 2000-07-14 2002-01-30 Allergan Sales Inc Compositions containing alpha-2-adrenergic agonist components
AU2005220199B2 (en) * 2000-07-14 2007-03-08 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
DE10132876A1 (de) * 2001-07-06 2003-01-30 Medproject Pharma Entwicklungs Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
EP1761266B1 (en) 2004-05-25 2013-05-08 Galderma Pharma S.A. Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
EP2329849B1 (en) 2009-11-18 2015-04-29 Galderma Research & Development Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
FR2977493B1 (fr) 2011-07-05 2014-02-14 Galderma Res & Dev Nouvelle composition anesthesique stable pour la reduction des reactions cutanees
EP2956096A1 (en) 2013-02-15 2015-12-23 Allergan, Inc. Sustained drug delivery implant
WO2014150899A1 (en) * 2013-03-15 2014-09-25 Chapin Matthew J Topical ophthalmic formulations for treating migraine
WO2016172712A2 (en) 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
EP3302426A4 (en) 2015-05-29 2018-12-05 Sydnexis, Inc. D2o stabilized pharmaceutical formulations
GB202110420D0 (en) * 2021-07-20 2021-09-01 Rosemont Pharmaceuticals Ltd Liquid pharmaceutical composition of clonidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
DD294174A5 (de) * 1990-05-04 1991-09-26 Sigrid Keipert Ophthalmika mit retardwirkung und ein neues verfahren zu ihrer herstellung
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
FR2679773A1 (fr) * 1991-07-30 1993-02-05 Merck Sharp & Dohme Preparation ophtalmique contenant un agent osmotique acceptable antimicrobien.
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Also Published As

Publication number Publication date
AP2000001977A0 (en) 2000-12-31
CA2326690A1 (en) 2000-08-31
WO2000049990A2 (en) 2000-08-31
EP1139970A2 (en) 2001-10-10
WO2000049990A3 (en) 2001-07-26
BR0004530A (pt) 2001-04-03
ZA200006252B (en) 2001-11-29
AU4429100A (en) 2000-09-14
IL138824A0 (en) 2001-10-31
EA200000918A1 (ru) 2001-10-22
ID28121A (id) 2001-05-03

Similar Documents

Publication Publication Date Title
BE2018C020I2 (el)
BE2015C057I2 (el)
BE2016C007I2 (el)
BE2015C018I2 (el)
BE2014C017I2 (el)
BE2013C051I2 (el)
BE2013C020I2 (el)
BE2013C001I2 (el)
BE2012C036I2 (el)
BE2011C004I2 (el)
BE2010C011I2 (el)
BE1025464I2 (el)
BE2008C046I2 (el)
JP2002509768A5 (el)
BRPI0017527B8 (el)
BE2008C047I2 (el)
BRPI0001672A2 (el)
JP2002514765A5 (el)
JP2002528831A5 (el)
JP2002540735A5 (el)
BRPI0001542A2 (el)
JP2002525154A5 (el)
JP2002524750A5 (el)
JP2002520972A5 (el)
IN185228B (el)